Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Israeli forces kill one person in series of attacks on southern Lebanon - 2How to Build a Yard That Helps Monarchs During Spring Migration
- 3Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
- 4US FDA grants market authorization to six on! PLUS nicotine pouch products
- 5Uzbekistan launches €9.46 billion green energy push, covering nation’s power needs
- Expert advice for new stargazers: How to begin your amateur astronomy journey
- Archaeologists uncover details about the Hjortspring boat's origins
- Ergonomic Office Seats for Work spaces
- A Manual for Nations to Head out To
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- Turning into a Distributed Writer: My Composing Process
- Southern Californians, your health insurance costs could rise in 2026
- What to watch for in weight loss drugs in 2026
- I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
